Clinical Trial Update: Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating a reduced-dose radiotherapy approach for stage III nasopharyngeal carcinoma, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING